These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Who should protect the public? The Supreme Court and medical device regulation. Korobkin R N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010 [No Abstract] [Full Text] [Related]
7. A pivotal medical-device case. Greenspan H N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514 [No Abstract] [Full Text] [Related]
8. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices. Mottes LM Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761 [No Abstract] [Full Text] [Related]
9. A pivotal medical-device case. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178 [No Abstract] [Full Text] [Related]
10. Why doctors should worry about preemption. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269 [No Abstract] [Full Text] [Related]
11. A pivotal medical-device case. Sonder G N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426012 [No Abstract] [Full Text] [Related]
12. Devices and the food and drug administration. Phillips SJ; Phillips RS Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210 [No Abstract] [Full Text] [Related]
14. The FDA's humanitarian device exemption program. Eydelman MB; Chen EA Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975 [No Abstract] [Full Text] [Related]
15. Regulation of medical devices in the United States and European Union. Kramer DB; Xu S; Kesselheim AS N Engl J Med; 2012 Mar; 366(9):848-55. PubMed ID: 22332952 [No Abstract] [Full Text] [Related]
16. Product safety and business interests: deja vu.. Rijswijk L Ostomy Wound Manage; 2005 Feb; 51(2):8-9. PubMed ID: 15699549 [No Abstract] [Full Text] [Related]
17. A humanitarian device exemption for deep brain stimulation. Alpert S Health Aff (Millwood); 2011 Jun; 30(6):1212; author reply 1212. PubMed ID: 21653977 [No Abstract] [Full Text] [Related]
18. The medical device safety act of 2009: clarifying preemption. Turcott RG; Ashley EA Am J Ther; 2009; 16(6):471-4. PubMed ID: 19940607 [No Abstract] [Full Text] [Related]
19. Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans. Hall RF; Sobotka E Food Drug Law J; 2007; 62(1):1-48. PubMed ID: 17444025 [No Abstract] [Full Text] [Related]
20. Judicial review of FDA preemption determinations. Frost A Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704 [No Abstract] [Full Text] [Related] [Next] [New Search]